IMMUNITYBIO, INC. Accrued Bonuses, Current
IMMUNITYBIO, INC. (IBRX) had Accrued Bonuses, Current of $3.93 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-05-07
- 2026-03-31: Accrued Bonuses, Current $3.93M.
- 2025-12-31: Accrued Bonuses, Current $14.35M.
- 2025-09-30: Accrued Bonuses, Current $10.30M.
- 2025-06-30: Accrued Bonuses, Current $7.05M.
| Period end | Accrued Bonuses, Current | Accrued Bonuses, Current as first filed |
|---|---|---|
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $14.35M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $10.30M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $7.05M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $3.67M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $10.35M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $9.72M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.39M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $3.27M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $11.35M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $8.90M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $17.49M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $14.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $12.07M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $8.74M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.75M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $3.05M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.32M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $5.56M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.38M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.95M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $5.29M 10-K · filed 2022-03-01 | $2.24M 10-K · filed 2021-03-04 |
| 2020-09-30 | $1.84M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.10M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $2.61M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.12M 8-K/A · filed 2021-04-22 | $2.00M 10-K · filed 2020-03-25 |
| 2019-09-30 | $1.60M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.51M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.65M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.08M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.94M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.60M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.48M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $1.93M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $1.43M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.24M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.38M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.73M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $1.62M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.18M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.80M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.36M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |